150
views
1
recommends
+1 Recommend
2 collections
    2
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Three-Component Solvent for the Treatment for COVID-19: Is the Data in Place for Clinical Trial?

      Preprint
      In review

        , 1 , 1 , 2

      UnisaRxiv

      UNISA Press

      COVID-19, treatment, protein, ethanol, alcohol

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This letter outlines the potential use of a three-component solvent, with strong anti-viral properties, as an economical and efficient treatment of COVID-19. It focuses on the generation and delivery of the alcohol-based solvent as nanodroplets deep within a patients lungs to reduce the viral load and potentially reduce the impact of a bradykinin or cytokine storm. The treatment is considered for compassionate use where other methods are not available or will not work.

          Related collections

          Author and article information

          Journal
          UnisaRxiv
          UNISA Press
          26 January 2021
          Affiliations
          [1 ] Valdosta State University, USA
          [2 ] Forrest General Hospital and Hattiesburg Clinic, USA
          Article
          10.25159/UnisaRxiv/000003.v1

          This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

          The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

          Medicine

          COVID-19, treatment, alcohol, protein, ethanol

          Comments

          Comment on this article